Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Cognition and Behavior

Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption

Nadine Schweizer, Thomas Viereckel, Casey J.A. Smith-Anttila, Karin Nordenankar, Emma Arvidsson, Souha Mahmoudi, André Zampera, Hanna Wärner Jonsson, Jonas Bergquist, Daniel Lévesque, Åsa Konradsson-Geuken, Malin Andersson, Sylvie Dumas and Åsa Wallén-Mackenzie
eNeuro 15 September 2016, 3 (5) ENEURO.0264-16.2016; DOI: https://doi.org/10.1523/ENEURO.0264-16.2016
Nadine Schweizer
1Department of Organismal Biology, Uppsala University, SE-752 36 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nadine Schweizer
Thomas Viereckel
1Department of Organismal Biology, Uppsala University, SE-752 36 Uppsala, Sweden
2Department of Neuroscience, Uppsala University, SE-751 24 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Viereckel
Casey J.A. Smith-Anttila
2Department of Neuroscience, Uppsala University, SE-751 24 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Nordenankar
2Department of Neuroscience, Uppsala University, SE-751 24 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Arvidsson
1Department of Organismal Biology, Uppsala University, SE-752 36 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Souha Mahmoudi
3Faculty of Pharmacy, Université de Montréal, Montréal, QC H3T 1J4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Zampera
4Oramacell, 75006 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna Wärner Jonsson
5Department of Pharmaceutical Biosciences, Uppsala University, SE-751 24 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas Bergquist
6Department of Chemistry, BMC - Analytical Chemistry and Neurochemistry, Uppsala University, SE-751 24 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Lévesque
3Faculty of Pharmacy, Université de Montréal, Montréal, QC H3T 1J4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Åsa Konradsson-Geuken
1Department of Organismal Biology, Uppsala University, SE-752 36 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Åsa Konradsson-Geuken
Malin Andersson
5Department of Pharmaceutical Biosciences, Uppsala University, SE-751 24 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Dumas
4Oramacell, 75006 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Åsa Wallén-Mackenzie
1Department of Organismal Biology, Uppsala University, SE-752 36 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Åsa Wallén-Mackenzie
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Strong overlap of Vglut2 and Pitx2 in the STN and reduction of Vglut2 mRNA in cKO mice. A, Representative examples of cell morphology and distribution. Overview of the STN (left) as well as close-up images of the dorsal (right top), ventral (right center), and medial (right bottom). Cells are stained blue; small dots represent silver grains bound to Vglut2 mRNA. B, Double fluorescent in situ hybridization for Vglut2 (red) and Pitx2 (green) as well as nuclear stain with DAPI (blue) in the dorsal (top), ventral (center), and medial (bottom) STN. C, High-resolution in situ hybridization analysis of Vglut2 mRNA-based silver grain intensity shows a generally lowered expression of Vglut2 in the STN of cKO mice.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Decreased consumption of sugar in STN-VGLUT2 cKO mice. A, Schematic self-administration schedule. Black lines indicate the number of days during which each paradigm was carried out. B, Operant self-administration was carried out in modular self-administration boxes with two feeders, one of which delivered pellets upon head entry (south, green = active), and the other did not (north, red = inactive). Yellow: house light. Black bars, head entry holes measuring exploration with no feeder attached. When a mouse made a head entry at the active feeder, a sugar reward was delivered, and simultaneously, light and sound cues were presented to confirm the choice (left); a head entry at the inactive feeder produced neither reward delivery nor a light or sound cue (right). C, During task learning, both controls (white circles) and cKOs (filled circles) decreased time to obtain the maximum of 30 sugar pellets. D, During FR1, the time to consume 30 pellets was significantly higher for cKO (filled circles) compared with control (white circles; left panel). All mice were able to obtain the maximum of 30 pellets during the FR1 protocol (middle panel). The amount of head entries during the inactive time (timeout) decreased in cKO and increased in control (right). E, During FR5, head entries during active time (left), the amount of pellets obtained (middle) and head entries during inactive time (right) were lower for cKO compared with controls. F, During PR, no difference was seen in head entries during the active (left) or the inactive (timeout, right) time between control and cKO mice. G, Cognitive ability testing. During reinstatement, the mice were presented to the original task after an extinction period (left). During reversal, the positions of the active and inactive feeders were switched (right). H, To allow testing of the retention of the task (reinstatement), both cKO and control groups were put through extinction. For five consecutive days, the active feeder delivered both light and sound cues, but no sugar pellets. For both groups, the amount of head entries strongly decreased during both the active time (left) and timeout (right). I, No differences between control and cKO mice were seen during reinstatement or reversal. Statistical analysis of the self-administration data was performed using repeated-measures ANOVA followed by a post hoc test with Bonferroni correction. # or *p ≤ 0.05; ## or **p ≤ 0.01; ### or ***p ≤ 0.001, #### or **** p ≤ 0.0001. Hab., habituation; Rev., reversal; RI, reinstatement.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    The average weight of STN-VGLUT2 cKO mice is decreased, whereas home cage food consumption is unaltered. A, Control mice (white circles) had a higher body weight than cKO mice (filled circles) over the course of the experiment. B, Refeeding after self-administration was not significantly different between controls and cKOs. Statistical analysis of weight and food intake data were analyzed using repeated-measures ANOVA followed by a post hoc test with Bonferroni correction. *p ≤ 0.05; **p ≤ 0.001.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Increased seated and free rearing in STN-VGLUT2 cKO mice. Three rearing types were observed in STN-VGLUT2 cKO mice: wall rearing, where the mouse takes support against a vertical surface (A, left); seated rearing, where the mouse supports itself on the tail base (B, left); and free rearing, where the mouse stretches its hind legs and uses no other support (C, left). All rearing types were scored in an open field arena. Both groups were habituated to the environment (# marks the change over time). cKOs show increased seated (B) and free (C) rearing throughout the session (¤ marks the difference between genotypes and * marks the difference at a certain time point between genotypes). Rearing data was analyzed by repeated-measures ANOVA and post hoc test with Bonferroni correction. *p ≤ 0.05; **p ≤ 0.001; ***p ≤ 0.0001.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    The availability of dopamine receptor D2 and D3 as well as DAT binding sites in the ventral striatum is regulated by Vglut2 reduction in the STN. A, Representative examples of serial coronal striatal sections analyzed for DAT, D1R, D2R, and D3R (from top to bottom). B, Comparison of specific binding capacity levels expressed as percentage of control for DAT-specific [125I]RTI binding, D1R-specific [3H]SCH23390, D2R-specific [125I]iodosulpride, and D3R-specific [125I]7-OH-PIPAT binding in control and cKO mice. DAT binding was unaltered in the NAcC and upregulated in the NAcSh of cKO mice (left). The amount of D1 receptor binding sites (middle left) in both NAcC and NAcSh remained unaltered, whereas more D2 receptor binding sites were measured in both NAcC and NAcSh (middle right) and fewer D3 receptor binding sites were available in NAcSh (right). Data analyzed by Mann–Whitney U-test. *p ≤ 0.05.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Elevated levels of dynorphin peptides in the NAc of STN-VGLUT2 cKO mice. A, MALDI analysis was performed on cryosections at the level of the DStr and NAc. Each slice was coated with droplets of matrix for ionization of the peptide fragments and analyzed by MALDI time-of-flight. B, A bright-field picture of the cresyl violet–stained section analyzed for aNeo was used to determine the localization of DStr and NAc (black outlines). Representative examples of aNeo (depicted in red) in cKO. Overlays with peptide fragment m/z 1835 and 1393 (middle and right, depicted in green) visualized the fiber bundles used as landmarks for the anatomical localization of the NAc. C, Representative examples of slices used for MALDI imaging in control (left) and cKO (right). aNeo and DynA peptide levels were significantly elevated in cKO and showed a more restricted localization to the NAc. D, Fluorescence intensity of different peptides measured by MALDI imaging, shown as percentage of control (fold change, see table). E, Example peaks of DynA (top) and aNeo (bottom) from MALDI analysis. F, Oligo in situ hybridization analysis of Dyn expression in the forebrain of control (left) and cKO (right) mice. FC: fold change; numbers in brackets indicate which amino acids constitute each peptide fragment. *p ≤ 0.05 and **p ≤ 0.01; error given as SEM.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Optogenetic tracing of Vglut2-Pitx2 coexpressing neurons revealed a projection pattern restricted to the EP and SNr. A–C, Schematic illustrations of injection procedure. A, Mice were stereotactically injected with AAV-ChR2-EYFP into the STN; B, The injection was performed bilaterally but one side at a time to infect the left- and righthand side STN at equal levels; C, Two close coordinates were used for each STN to allow even spread of the virus (–4.25 and –4.75 dorsoventricular). D, Histologic results of injections. AAV-ChR2-EYFP–positive cell bodies in the STN. E, AAV-ChR2-EYFP–positive fibers projecting to EP (left), GP (middle), and SNr (right). Upper row, EYFP expression; bottom row, bright-field photographs of the same area. PSTN: parasubthalamic nucleus.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Vglut2 reduction leads to cell loss and reduction in size of STN. A, Cell size is increased in cKO (black bars) mice compared with controls (white bars). The cKO mice show a much wider spread of cell size than controls. B, Representative pictures of STN morphology in cKO and control. The STN of cKO mice appears slimmer compared with controls. The white outlines were used for 2D and 3D analysis of STN morphology. C, Two-dimensional analysis of STN morphology. The size of the STN was assessed by measuring the diameter of the STN at its widest point and comparing it to the diameter of the cerebral peduncle (cp) and the total diameter of both structures at the same point. D, Representative example of a control (left, red) and a cKO STN (middle, green), and their overlay (right). Both diameter (white dotted line) and volume of the cKO STN is reduced compared with the control. Three-dimensional reconstruction was obtained with MATLAB from 16 and 27 images of a cKO and a control, respectively.

Back to top

In this issue

eneuro: 3 (5)
eNeuro
Vol. 3, Issue 5
September/October 2016
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption
Nadine Schweizer, Thomas Viereckel, Casey J.A. Smith-Anttila, Karin Nordenankar, Emma Arvidsson, Souha Mahmoudi, André Zampera, Hanna Wärner Jonsson, Jonas Bergquist, Daniel Lévesque, Åsa Konradsson-Geuken, Malin Andersson, Sylvie Dumas, Åsa Wallén-Mackenzie
eNeuro 15 September 2016, 3 (5) ENEURO.0264-16.2016; DOI: 10.1523/ENEURO.0264-16.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption
Nadine Schweizer, Thomas Viereckel, Casey J.A. Smith-Anttila, Karin Nordenankar, Emma Arvidsson, Souha Mahmoudi, André Zampera, Hanna Wärner Jonsson, Jonas Bergquist, Daniel Lévesque, Åsa Konradsson-Geuken, Malin Andersson, Sylvie Dumas, Åsa Wallén-Mackenzie
eNeuro 15 September 2016, 3 (5) ENEURO.0264-16.2016; DOI: 10.1523/ENEURO.0264-16.2016
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • dopamine
  • dynorphin
  • glutamate
  • Rearing
  • reward
  • self-administration

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • Distinguishing fine structure and summary representation of sound textures from neural activity
  • Anatomical Connectivity of the Intercalated Cells of the Amygdala
  • Spatiotemporal regulation of de novo and salvage purine synthesis during brain development
Show more New Research

Cognition and Behavior

  • Distinguishing fine structure and summary representation of sound textures from neural activity
  • Dopamine Receptor Type 2-Expressing Medium Spiny Neurons in the Ventral Lateral Striatum Have a Non-REM Sleep-Induce Function
  • How Sucrose Preference Is Gained and Lost: An In-Depth Analysis of Drinking Behavior during the Sucrose Preference Test in Mice
Show more Cognition and Behavior

Subjects

  • Cognition and Behavior

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.